
    
      In this study we will prospectively analyze the benefit of inhaled furosemide for preterm and
      term neonates with transient Tachypnoea. Patients received nebulised Furosemide iv solution 1
      mg/kg or nebulised 0,9% saline (4x/d) under blind conditions in random order so long as need
      a CPAP-treatment but max. 3 days. 20 Patient will be treating.

      The benefit will be measured as reduction of dyspnea, respiratory rate, oxygen demand and
      time on CPAP.
    
  